Bioventus Inc. (BVS) stock
BVSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 2, 2026Score 13/3041% below fair value
$10.62+0.02 (+0.19%)
Close on Nov 18, 2026Market cap $893.06MP/E 13.8Yield –
Bioventus free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Bioventus's free cash flow for the twelve months ending Jun 27, 2026 was $94.29M, up 176.5% year over year. For fiscal 2025 it was $72.11M, up 90.8% from the year before. The highest annual figure on record is $72.11M in fiscal 2025.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $72.11M | +90.8% |
| FY2024 | Dec 31, 2024 | $37.79M | +373.4% |
| FY2023 | Dec 31, 2023 | $7.98M | – |
| FY2022 | Dec 31, 2022 | -$15.02M | -258.5% |
| FY2021 | Dec 31, 2021 | $9.47M | -82.8% |
| FY2020 | Dec 31, 2020 | $55.22M | +43.9% |
| FY2019 | Dec 31, 2019 | $38.37M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 27, 2026 | $18.91M | -25.1% |
| Q1 FY2026 | Mar 28, 2026 | $8.36M | – |
| Q4 FY2025 | Dec 31, 2025 | $37.39M | +99.4% |
| Q3 FY2025 | Sep 27, 2025 | $29.63M | +189.0% |
| Q2 FY2025 | Jun 28, 2025 | $25.26M | +67.4% |
| Q1 FY2025 | Mar 29, 2025 | -$20.16M | – |
| Q4 FY2024 | Dec 31, 2024 | $18.75M | +87.4% |
| Q3 FY2024 | Sep 28, 2024 | $10.25M | – |
| Q2 FY2024 | Jun 29, 2024 | $15.09M | +60.5% |
| Q1 FY2024 | Mar 30, 2024 | -$6.30M | – |
| Q4 FY2023 | Dec 31, 2023 | $10.01M | -3.8% |
| Q3 FY2023 | Sep 30, 2023 | -$10.35M | – |
| Q2 FY2023 | Jul 1, 2023 | $9.40M | +933.9% |
| Q1 FY2023 | Apr 1, 2023 | -$1.07M | – |
| Q4 FY2022 | Dec 31, 2022 | $10.41M | +149.8% |
| Q3 FY2022 | Oct 1, 2022 | -$2.35M | -127.1% |
| Q2 FY2022 | Jul 2, 2022 | $909.00K | -94.3% |
| Q1 FY2022 | Apr 2, 2022 | -$23.98M | – |
| Q4 FY2021 | Dec 31, 2021 | $4.17M | -62.8% |
| Q3 FY2021 | Oct 2, 2021 | $8.66M | -55.7% |
| Q2 FY2021 | Jul 3, 2021 | $16.06M | +127.1% |
| Q1 FY2021 | Apr 3, 2021 | -$19.41M | -211.6% |
| Q4 FY2020 | Dec 31, 2020 | $11.20M | – |
| Q3 FY2020 | Sep 26, 2020 | $19.56M | – |
| Q2 FY2020 | Jun 27, 2020 | $7.07M | – |
| Q1 FY2020 | Mar 28, 2020 | $17.39M | – |
See a number that looks wrong?